The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Chalcone Derivatives: Promising Starting Points for Drug Design
Open accessAbstract
Medicinal chemists continue to be fascinated by chalcone derivatives because of their simple chemistry, ease of hydrogen atom manipulation, straightforward synthesis, and a variety of promising biological activities. However, chalcones have still not garnered deserved attention, especially considering their high potential as chemical sources for designing and developing new effective drugs. In this review, we summarize current methodological developments towards the design and synthesis of new chalcone derivatives and state-of-the-art medicinal chemistry strategies (bioisosterism, molecular hybridization, and pro-drug design). We also highlight the applicability of computer-assisted drug design approaches to chalcones and address how this may contribute to optimizing research outputs and lead to more successful and cost-effective drug discovery endeavors. Lastly, we present successful examples of the use of chalcones and suggest possible solutions to existing limitations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins
MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J., Fischer, S., Gao, J., Guo, H., Ha, S., et al. (1998) · The Journal of Physical Chemistry B · doi:10.1021/jp973084f · Cited by 14,311
A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules
Cornell, W. D., Cieplak, P., Bayly, C. I., Gould, I. R., Merz, K. M., Ferguson, D. M., Spellmeyer, D. C., Fox, T., Caldwell, J. W., & Kollman, P. A. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00124a002 · Cited by 13,103
The Nature of Statistical Learning Theory
Vapnik, V. N. (2000) · Springer eBooks · doi:10.1007/978-1-4757-3264-1 · Cited by 10,696
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
The Many Roles for Fluorine in Medicinal Chemistry
Hagmann, W. K. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800219f · Cited by 3,578
Improved protein–ligand docking using GOLD
Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W., & Taylor, R. D. (2003) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10465 · Cited by 3,067
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
Molecular Docking and Structure-Based Drug Design Strategies
Ferreira, L., Dos Santos, R., Oliva, G., & Andricopulo, A. (2015) · Molecules · doi:10.3390/molecules200713384 · Cited by 2,528
QSAR Modeling: Where have you been? Where are you going to?
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164
Self-citationBest Practices for QSAR Model Development, Validation, and Exploitation
Tropsha, A. (2010) · Molecular Informatics · doi:10.1002/minf.201000061 · Cited by 2,024
Murray, H. W., Berman, J. D., Davies, C. R., & Saravia, N. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67629-5 · Cited by 1,771
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,630
Bioisosterism: A Rational Approach in Drug Design
Patani, G. A., & LaVoie, E. J. (1996) · Chemical Reviews · doi:10.1021/cr950066q · Cited by 1,328
Molecular Hybridization: A Useful Tool in the Design of New Drug Prototypes
Viegas-Junior, C., Barreiro, E. J., & Fraga, C. A. M. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781058805 · Cited by 1,302
Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances
Lionta, E., Spyrou, G., Vassilatis, D., & Cournia, Z. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140929124445 · Cited by 1,165
A Convenient Synthesis of Ethynylarenes and Diethynylarenes
Takahashi, S., Kuroyama, Y., Sonogashira, K., & Hagihara, N. (1980) · Synthesis · doi:10.1055/s-1980-29145 · Cited by 1,085
Grygiel-Górniak, B. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-17 · Cited by 1,079
Liu, X., Ouyang, S., Yu, B., Liu, Y., Huang, K., Gong, J., Zheng, S., Li, Z., Li, H., & Jiang, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq300 · Cited by 967
Computer-based de novo design of drug-like molecules
Schneider, G., & Fechner, U. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1799 · Cited by 948
Molecular fingerprint similarity search in virtual screening
Cereto-Massagué, A., Ojeda, M. J., Valls, C., Mulero, M., Garcia-Vallvé, S., & Pujadas, G. (2015) · Methods · doi:10.1016/j.ymeth.2014.08.005 · Cited by 846
Fourches, D., Muratov, E., & Tropsha, A. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100176x · Cited by 832
Self-citationComprehensive Organic Name Reactions and Reagents
Wang, Z. (2010) · Wiley eBooks · doi:10.1002/9780470638859 · Cited by 769
Role of computer-aided drug design in modern drug discovery
Macalino, S. J. Y., Gosu, V., Hong, S., & Choi, S. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0640-5 · Cited by 762
Virtual screening with AutoDock: theory and practice
Cosconati, S., Forli, S., Perryman, A. L., Harris, R., Goodsell, D. S., & Olson, A. J. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.484460 · Cited by 695
Bioisosterism: A Useful Strategy for Molecular Modification and Drug Design
Lima, L., & Barreiro, E. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053363540 · Cited by 672
Exploring Pharmacological Significance of Chalcone Scaffold: A Review
K. Sahu, N., S. Balbhadra, S., Choudhary, J., & V. Kohli, D. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803414132 · Cited by 582
Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)
Wermuth, C. G., Ganellin, C. R., Lindberg, P., & Mitscher, L. A. (1998) · Pure and Applied Chemistry · doi:10.1351/pac199870051129 · Cited by 529
The RCSB Protein Data Bank: views of structural biology for basic and applied research and education
Rose, P. W., Prlić, A., Bi, C., Bluhm, W. F., Christie, C. H., Dutta, S., Green, R. K., Goodsell, D. S., Westbrook, J. D., Woo, J., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1214 · Cited by 515
FRED and HYBRID docking performance on standardized datasets
McGann, M. (2012) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-012-9584-8 · Cited by 503
Machine learning methods in chemoinformatics
Mitchell, J. B. O. (2014) · WIREs Computational Molecular Science · doi:10.1002/wcms.1183 · Cited by 469
Parametrization of aliphatic CHn united atoms of GROMOS96 force field
Daura, X., Mark, A. E., & Van Gunsteren, W. F. (1998) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(19980415)19:5<535::aid-jcc6>3.0.co;2-n · Cited by 408
Molecular dynamics-driven drug discovery: leaping forward with confidence
Ganesan, A., Coote, M. L., & Barakat, K. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.11.001 · Cited by 357
Recent advances in leishmaniasis treatment
Tiuman, T. S., Santos, A. O., Ueda-Nakamura, T., Filho, B. P. D., & Nakamura, C. V. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.03.021 · Cited by 345
Structure-based drug design to augment hit discovery
Kalyaanamoorthy, S., & Chen, Y.-P. P. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.07.006 · Cited by 296
Trust, but Verify II: A Practical Guide to Chemogenomics Data Curation
Fourches, D., Muratov, E., & Tropsha, A. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00129 · Cited by 294
Self-citationThe Prodrug Approach: A Successful Tool for Improving Drug Solubility
Jornada, D., Dos Santos Fernandes, G., Chiba, D., De Melo, T., Dos Santos, J., & Chung, M. (2015) · Molecules · doi:10.3390/molecules21010042 · Cited by 294
Malarial hemozoin: From target to tool
Coronado, L. M., Nadovich, C. T., & Spadafora, C. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.02.009 · Cited by 289
Kamerlin, S. C. L., Haranczyk, M., & Warshel, A. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp8071712 · Cited by 281
An overview of molecular fingerprint similarity search in virtual screening
Muegge, I., & Mukherjee, P. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1117070 · Cited by 277
Chemogenomic approaches to rational drug design
Rognan, D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707307 · Cited by 269
Phantom PAINS: Problems with the Utility of Alerts for P an-A ssay IN terference Compound S
Capuzzi, S. J., Muratov, E. N., & Tropsha, A. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00465 · Cited by 260
Self-citationState-of-the-art in ligand-based virtual screening
Ripphausen, P., Nisius, B., & Bajorath, J. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.011 · Cited by 240
Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization
Langdon, S. R., Ertl, P., & Brown, N. (2010) · Molecular Informatics · doi:10.1002/minf.201000019 · Cited by 224
Chen, M., Christensen, S. B., Blom, J., Lemmich, E., Nadelmann, L., Fich, K., Theander, T. G., & Kharazmi, A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.12.2550 · Cited by 221
MM-GB/SA Rescoring of Docking Poses in Structure-Based Lead Optimization
Guimarães, C. R. W., & Cardozo, M. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800004w · Cited by 219
Chalcone scaffolds as anti-infective agents: Structural and molecular target perspectives
Mahapatra, D. K., Bharti, S. K., & Asati, V. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.06.052 · Cited by 206
Recent advances in therapeutic chalcones
Ni, L., Meng, C. Q., & Sikorski, J. A. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.12.1669 · Cited by 203
Diverse Molecular Targets for Chalcones with Varied Bioactivities
Zhou, B. (2015) · Medicinal Chemistry · doi:10.4172/2161-0444.1000291 · Cited by 195
Curation of chemogenomics data
Fourches, D., Muratov, E., & Tropsha, A. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1881 · Cited by 192
Self-citationHistone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer
DAMASKOS, C., VALSAMI, S., KONTOS, M., SPARTALIS, E., KALAMPOKAS, T., KALAMPOKAS, E., ATHANASIOU, A., MORIS, D., DASKALOPOULOU, A., DAVAKIS, S., et al. (2017) · Anticancer Research · doi:10.21873/anticanres.11286 · Cited by 192
ISRAF, D., KHAIZURIN, T., SYAHIDA, A., LAJIS, N., & KHOZIRAH, S. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.04.025 · Cited by 190
Antibacterial chalcones––bioisosteric replacement of the 4′-hydroxy group
Nielsen, S. F., Boesen, T., Larsen, M., Schønning, K., & Kromann, H. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.03.071 · Cited by 183
Targeting Class I Histone Deacetylases in a “Complex” Environment
Millard, C. J., Watson, P. J., Fairall, L., & Schwabe, J. W. R. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.12.006 · Cited by 180
Software and Resources for Computational Medicinal Chemistry
Liao, C., Sitzmann, M., Pugliese, A., & Nicklaus, M. C. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.63 · Cited by 177
Structure-Based Drug Design Strategies in Medicinal Chemistry
Andricopulo, A., Salum, L., & Abraham, D. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789207127 · Cited by 161
Ligand−Protein Docking with Water Molecules
Roberts, B. C., & Mancera, R. L. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci700285e · Cited by 155
Chemogenomic approaches to drug discovery: similar receptors bind similar ligands
Klabunde, T. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707308 · Cited by 155
A Proton-Shuttle Reaction Mechanism for Histone Deacetylase 8 and the Catalytic Role of Metal Ions
Wu, R., Wang, S., Zhou, N., Cao, Z., & Zhang, Y. (2010) · Journal of the American Chemical Society · doi:10.1021/ja103932d · Cited by 153
Receptor-based virtual screening protocol for drug discovery
Cerqueira, N. M. F. S. A., Gesto, D., Oliveira, E. F., Santos‐Martins, D., Brás, N. F., Sousa, S. F., Fernandes, P. A., & Ramos, M. J. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.05.011 · Cited by 151
Birari, R. B., Gupta, S., Mohan, C. G., & Bhutani, K. K. (2011) · Phytomedicine · doi:10.1016/j.phymed.2011.01.002 · Cited by 150
Gomes, M. D. N., Braga, R. C., Grzelak, E. M., Neves, B. J., Muratov, E. N., Ma, R., Klein, L. L., Cho, S., de Oliveira, G. R., Franzblau, S. G., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.05.026 · Cited by 138
Self-citationIsosterism and bioisosterism in drug design
Burger, A. (1991) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7139-6_7 · Cited by 136
Prediction of Michael-Type Acceptor Reactivity toward Glutathione
Schwöbel, J. A. H., Wondrousch, D., Koleva, Y. K., Madden, J. C., Cronin, M., & Schüürmann, G. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100172x · Cited by 136
Vuorinen, A., & Schuster, D. (2014) · Methods · doi:10.1016/j.ymeth.2014.10.013 · Cited by 133
The role of fibrate treatment in dyslipidemia: an overview
Katsiki, N., Nikolic, D., Montalto, G., Banach, M., Mikhailidis, D. P., & Rizzo, M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319170020 · Cited by 131
Quantum Mechanical Methods for Drug Design
Zhou, T., Danzhi Huang, A., & Caflisch, A. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790232242 · Cited by 130
How far can virtual screening take us in drug discovery?
Kar, S., & Roy, K. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.761204 · Cited by 128
Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives
Sashidhara, K. V., Kumar, A., Kumar, M., Srivastava, A. K., & Puri, A. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.055 · Cited by 121
QM/MM free energy simulations: recent progress and challenges
Lu, X., Fang, D., Ito, S., Okamoto, Y., Ovchinnikov, V., & Cui, Q. (2016) · Molecular Simulation · doi:10.1080/08927022.2015.1132317 · Cited by 121
Sato, Y., He, J.-X., Nagai, H., Tani, T., & Akao, T. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.145 · Cited by 117
Structure-based design of parasitic protease inhibitors
Li, R., Chen, X., Gong, B., Selzer, P. M., Li, Z., Davidson, E. A., Kurzban, G. P., Miller, R. E., Nuzum, E. O., McKerrow, J. H., et al. (1996) · Bioorganic & Medicinal Chemistry · doi:10.1016/0968-0896(96)00136-8 · Cited by 116
Protein Flexibility and Ligand Recognition: Challenges for Molecular Modeling
Spyrakis, F., Bidon‐Chanal, A., Barril, X., & Luque, F. J. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611794863571 · Cited by 116
Assessing the Performance of 3D Pharmacophore Models in Virtual Screening: How Good are They?
Braga, R. C., & Andrade, C. H. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313090010 · Cited by 114
Self-citationMechanism of malarial haem detoxification inhibition by chloroquine
Pandey, A. V., BISHT, H., Babbarwal, V., SRIVASTAVA, J., PANDEY, K. C., & Chauhan, V. S. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3550333 · Cited by 109
Targeting histone deacetylases in T-cell lymphoma
Moskowitz, A. J., & Horwitz, S. M. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1247956 · Cited by 109
Small Neutralizing Molecules to Inhibit Actions of the Chemokine CXCL12
Hachet‐Haas, M., Balabanian, K., Rohmer, F., Pons, F., Franchet, C., Lecat, S., Chow, K. Y. C., Dagher, R., Gizzi, P., Didier, B., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803947200 · Cited by 107
Building a virtual ligand screening pipeline using free software: a survey
Glaab, E. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv037 · Cited by 106
The role of protonation states in ligand-receptor recognition and binding.
Petukh, M., Stefl, S., & Alexov, E. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319230004 · Cited by 101
Aranha, O., Grignon, R., Fernandes, N., McDonnell, T. J., Wood, D. P., & Sarkar, F. (2003) · International Journal of Oncology · doi:10.3892/ijo.22.4.787 · Cited by 99
pKa based protonation states and microspecies for protein–ligand docking
ten Brink, T., & Exner, T. E. (2010) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-010-9385-x · Cited by 99
Rashid, U., Sultana, R., Shaheen, N., Hassan, S. F., Yaqoob, F., Ahmad, M. J., Iftikhar, F., Sultana, N., Asghar, S., Yasinzai, M., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.022 · Cited by 97
Neves, B. J., Dantas, R. F., Senger, M. R., Melo-Filho, C. C., Valente, W. C. G., de Almeida, A. C. M., Rezende-Neto, J. M., Lima, E. F. C., Paveley, R. A., Furnham, N., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b02038 · Cited by 97
Self-citationMethods and Applications of Structure Based Pharmacophores in Drug Discovery
Pirhadi, S., Shiri, F., & Ghasemi, J. B. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313090006 · Cited by 96
Kim, D. W., Long, M. J. C., Yuk, H. J., Wang, Y., Song, Y. H., Jeong, S. H., & Park, K. H. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.12.026 · Cited by 96
Filtering promiscuous compounds in early drug discovery: is it a good idea?
Senger, M. R., Fraga, C. A. M., Dantas, R. F., & Silva, F. P. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.004 · Cited by 95
Drug Resistance in Leishmaniasis: Current Drug-Delivery Systems and Future Perspectives
Yasinzai, M., Khan, M., Nadhman, A., & Shahnaz, G. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.143 · Cited by 90
Brown, S. P., & Muchmore, S. W. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050488t · Cited by 89
A new class of furoxan derivatives as NO donors: mechanism of action and biological activity
Ferioli, R., Folco, G., Ferretti, C., Gasco, A., Medana, C., Fruttero, R., Civelli, M., & Gasco, A. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13277.x · Cited by 86
Cardiovascular actions of the furoxan CAS 1609, a novel nitric oxide donor
Bohn, H., Brendel, J., Martorana, P. A., & Schönafinger, K. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb14946.x · Cited by 85
Antivascular and antitumor properties of the tubulin-binding chalcone TUB091
Canela, M., Noppen, S., Bueno, O., Prota, A. E., Bargsten, K., Sáez-Calvo, G., Jimeno, M. L., Benkheil, M., Ribatti, D., Velázquez, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9527 · Cited by 78
Pharmacophore Modelling: A Forty Year Old Approach and its Modern Synergies
Caporuscio, F., & Tafi, A. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795933669 · Cited by 75
Mechanism of malarial haem detoxification inhibition by chloroquine
Pandey, A. V., BISHT, H., BABBARWAL, V. K., SRIVASTAVA, J., Pandey, K. C., & Chauhan, V. S. (2001) · Biochemical Journal · doi:10.1042/bj3550333 · Cited by 71
Accommodating Protein Flexibility for Structure-Based Drug Design
Lin, J. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611794863580 · Cited by 68
Per Aspera Ad Astra : Application of Simplex Qsar Approach in Antiviral Research
Muratov, E. N., Artemenko, A. G., Varlamova, E. V., Polischuk, P. G., Lozitsky, V. P., Fedchuk, A. S., Lozitska, R. L., Gridina, T. L., Koroleva, L. S., Sil’nikov, V. N., et al. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.194 · Cited by 64
Self-citationInduced fit docking, and the use of QM/MM methods in docking
Xu, M., & Lill, M. A. (2013) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2013.02.003 · Cited by 57
QSAR-Driven Discovery of Novel Chemical Scaffolds Active against Schistosoma mansoni
Melo-Filho, C. C., Dantas, R. F., Braga, R. C., Neves, B. J., Senger, M. R., Valente, W. C. G., Rezende-Neto, J. M., Chaves, W. T., Muratov, E. N., Paveley, R. A., et al. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00055 · Cited by 56
Self-citationSashidhara, K. V., Avula, S. R., Palnati, G. R., Singh, S. V., Srivastava, K., Puri, S., & Saxena, J. K. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.028 · Cited by 53
Higuchi, K., Watanabe, T., Tanigawa, T., Tominaga, K., Fujiwara, Y., & Arakawa, T. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06232.x · Cited by 51
New drugs for the treatment of Mycobacterium tuberculosis infection
AlMatar, M., AlMandeal, H., Var, İ., Kayar, B., & Köksal, F. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.105 · Cited by 49
Reactivity assessment of chalcones by a kinetic thiol assay
Amslinger, S., Al‐Rifai, N., Winter, K., Wörmann, K., Scholz, R., Baumeister, P., & Wild, M. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob27163j · Cited by 48
Huggins, D. J., & Tidor, B. (2011) · Protein Engineering Design and Selection · doi:10.1093/protein/gzr036 · Cited by 48
Mechanisms of action and resistance to tubulin-binding agents
Dumontet, C. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.4.779 · Cited by 47
Computational Design of a Time-Dependent Histone Deacetylase 2 Selective Inhibitor
Zhou, J., Li, M., Chen, N., Wang, S., Luo, H., Zhang, Y., & Wu, R. (2014) · ACS Chemical Biology · doi:10.1021/cb500767c · Cited by 47
Efficient Coupling Reactions of Arylalkynes and Aldehydes Leading to the Synthesis of Enones
Xu, L., Li, L., Xia, C., & Zhao, P. (2004) · Helvetica Chimica Acta · doi:10.1002/hlca.200490276 · Cited by 44
Highly Selective Continuous‐Flow Synthesis of Potentially Bioactive Deuterated Chalcone Derivatives
Hsieh, C., Ötvös, S. B., Wu, Y., Mándity, I. M., Chang, F., & Fülöp, F. (2015) · ChemPlusChem · doi:10.1002/cplu.201402426 · Cited by 44
Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents
Sashidhara, K. V., Dodda, R. P., Sonkar, R., Palnati, G. R., & Bhatia, G. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.085 · Cited by 44
Modelling and enhanced molecular dynamics to steer structure-based drug discovery
Kalyaanamoorthy, S., & Chen, Y. P. (2013) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2013.06.004 · Cited by 43
Ciprofloxacin inhibits proliferation and promotes generation of aneuploidy in Jurkat cells.
Kozieł, R., Szczepanowska, J., Magalska, A., Piwocka, K., Duszyński, J., & Zabłocki, K. (2010) · PubMed · Cited by 42
Pan-assay interference compounds (PAINS) that may not be too painful for chemical biology projects
Lagorce, D., Oliveira, N., Miteva, M. A., & Villoutreix, B. O. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.05.017 · Cited by 41
Kaur, J., Sundar, S., & Singh, N. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq189 · Cited by 39
Gasparik, V., Daubeuf, F., Hachet‐Haas, M., Rohmer, F., Gizzi, P., Haiech, J., Galzi, J., Hibert, M., Bonnet, D., & Frossard, N. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200017d · Cited by 34
Ötvös, S. B., Hsieh, C., Wu, Y., Li, J., Chang, F., & Fülöp, F. (2016) · Molecules · doi:10.3390/molecules21030318 · Cited by 34
Structure‐Based Pharmacophores for Virtual Screening
Löwer, M., & Proschak, E. (2011) · Molecular Informatics · doi:10.1002/minf.201100007 · Cited by 33
Hou, X., Li, K., Yu, X., Sun, J., & Fang, H. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00344 · Cited by 30
QSAR and QM/MM Approaches Applied to Drug Metabolism Prediction
Braga, R. C., & Andrade, C. H. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712800493807 · Cited by 30
Self-citationGomes, M. D. N., Alcântara, L. M., Neves, B. J., Melo-Filho, C. C., Freitas-Junior, L. H., Moraes, C. B., Ma, R., Franzblau, S. G., Muratov, E. N., & Andrade, C. H. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.04.010 · Cited by 27
Self-citationModern approaches to accelerate discovery of new antischistosomal drugs
Neves, B. J., Muratov, E. N., Machado, R. B., Andrade, C. H., & Cravo, P. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1178230 · Cited by 25
Self-citationImpact of Computational Structure-based Methods on Drug Discovery
Reynolds, C. H. (2014) · Current Pharmaceutical Design · doi:10.2174/138161282020140528105532 · Cited by 22
The use of fluvastatin in cardiovascular risk management
McDonald, K. J., & Jardine, A. G. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.8.1407 · Cited by 6
Cited by
Chalcone Derivatives: Role in Anticancer Therapy
Ouyang, Y., Li, J., Chen, X., Fu, X., Sun, S., & Wu, Q. (2021) · Biomolecules · doi:10.3390/biom11060894 · Cited by 399
Salehi, B., Quispe, C., Chamkhi, I., El Omari, N., Balahbib, A., Sharifi-Rad, J., Bouyahya, A., Akram, M., Iqbal, M., Docea, A. O., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.592654 · Cited by 351
Metadata
- Authors
- Gomes, M., Muratov, E., Pereira, M., Peixoto, J., Rosseto, L., Cravo, P., Andrade, C., & Neves, B.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2017-07-25
- Volume
- 22
- Issue
- 8
- Pages
- 1210
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2736732523
- Cited by
- 418
- References
- 124
- FWCI
- 12.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.